Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Founded in 2016, Hexagon Bio is backed by investors that include 8VC, Two Sigma Ventures, and The Column Group and is headquartered in Menlo Park.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
